Figures & data
Figure 1 Flow diagram of the study selection process.
![Figure 1 Flow diagram of the study selection process.](/cms/asset/ac7f2041-cd38-4c3d-8648-53eaeb5a1e33/dott_a_12195456_f0001_b.jpg)
Table 1 Main characteristics of studies included in the meta-analysis
Figure 2 Forest plot of SDF1-3′A polymorphism and the risk of hematological malignancy under a homozygote genetic model (AA vs GG).
![Figure 2 Forest plot of SDF1-3′A polymorphism and the risk of hematological malignancy under a homozygote genetic model (AA vs GG).](/cms/asset/6e432592-e33b-4309-a5a6-ee023b9bccff/dott_a_12195456_f0002_b.jpg)
Table 2 Main results of the meta–analysis of the pooled OR
Figure 3 Subgroup analysis of the association between SDF1-3′A polymorphism and the risk of hematological malignancy in different ethnicities under a homozygote genetic model (AA vs GG).
![Figure 3 Subgroup analysis of the association between SDF1-3′A polymorphism and the risk of hematological malignancy in different ethnicities under a homozygote genetic model (AA vs GG).](/cms/asset/ba81a06a-337b-4b53-8f98-20d4f0c86afa/dott_a_12195456_f0003_b.jpg)
Figure 4 Subgroup analysis of the association between SDF1-3′A polymorphism and the risk of different types of hematological malignancy under a homozygote genetic model (AA vs GG).
![Figure 4 Subgroup analysis of the association between SDF1-3′A polymorphism and the risk of different types of hematological malignancy under a homozygote genetic model (AA vs GG).](/cms/asset/11e53f6f-6dd8-4364-bfe1-58ac56cbed29/dott_a_12195456_f0004_c.jpg)
Figure 5 Sensitivity analysis of the relationships of SDF1-3′A polymorphism with the risk of hematological malignancy.
![Figure 5 Sensitivity analysis of the relationships of SDF1-3′A polymorphism with the risk of hematological malignancy.](/cms/asset/5389527d-a961-4040-9c66-4080e29a073a/dott_a_12195456_f0005_b.jpg)
Figure 6 Funnel plot of SDF1-3′A polymorphism and the risk of hematological malignancy under a homozygote genetic model (AA vs GG).
![Figure 6 Funnel plot of SDF1-3′A polymorphism and the risk of hematological malignancy under a homozygote genetic model (AA vs GG).](/cms/asset/448f6623-0193-4320-b04b-0cd3fb70db2f/dott_a_12195456_f0006_b.jpg)